Zoetis Inc
NYSE:ZTS
Zoetis Inc
NYSE:ZTS
Price:
122.665
USD
-1.82%
Market Closed
Market Cap:
$54.1B
Relative Value
The Relative Value of one
ZTS
stock under the Base Case scenario is
146.076
USD.
Compared to the current market price of 122.665 USD,
Zoetis Inc
is
Undervalued by 16%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ZTS
Relative Value
Base Case
146.076
USD
Undervaluation 16%
Multiples Across Competitors
ZTS Competitors Multiples
Zoetis Inc Competitors
Zoetis Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Zoetis Inc
NYSE:ZTS
|
54.2B USD | 5.7 | 20.3 | 14.4 | 16.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
948.8B USD | 16 | 51.5 | 34.6 | 37.1 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
563B USD | 6 | 21 | 14.6 | 17.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
282.3B CHF | 4.6 | 30.3 | 12.8 | 14.9 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
211.8B GBP | 5.1 | 31.3 | 15 | 21.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
288.1B USD | 4.5 | 15.1 | 10.7 | 12.7 | |
| CH |
|
Novartis AG
SIX:NOVN
|
223B CHF | 5.1 | 19.7 | 12.4 | 16 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.3 | 13 | 9.1 | 10.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
146.4B USD | 2.3 | 14.9 | 7.6 | 10.3 | |
| FR |
|
Sanofi SA
PAR:SAN
|
98.2B EUR | 1.7 | 8.2 | 7.7 | 7.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
